Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab pembrolizumab who makes?

See the DrugPatentWatch profile for Nivolumab

Who makes nivolumab and pembrolizumab?

  • Nivolumab is made by Bristol Myers Squibb (BMS). [1]
  • Pembrolizumab is made by Merck & Co. (MSD outside the US/Canada). [2]

Are there other companies making these drugs (or versions of them)?

Both drugs are brand biologics with manufacturer-defined supply chains for the original products (BMS for nivolumab, Merck for pembrolizumab). Over time, additional manufacturers may appear through biosimilar approvals, but the original brand product is associated with the companies above. [1][2]

Where to verify the maker for each drug?

DrugPatentWatch.com tracks branded products and related patent information and lists the manufacturer tied to each product page:
- Nivolumab: [1]
- Pembrolizumab: [2]

Sources

  1. DrugPatentWatch.com – Nivolumab (maker)
  2. DrugPatentWatch.com – Pembrolizumab (maker)


Other Questions About Nivolumab :

nivolumab patent expiry date brazil: opdivo® (nivolumab) lost exclusivity following the expiration of its patent on may 2, 2026, allowing for potential entry of competitive alternatives in the market. nivolumabe brand spc nivolumab ph20 patent patente de nivolumab Is nivolumab's dosage adjusted based on patient response? How does nivolumab impact patient's quality of life?